The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 16 July 2001. doi:10.1084/jem.194.2.155
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 369K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borges, V. M.
Right arrow Articles by DosReis, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borges, V. M.
Right arrow Articles by DosReis, G. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2001/7/155/ $5.00
The Journal of Experimental Medicine, Volume 194, Number 2, July 16, 2001 155-164


Original Article

Fas Ligand Triggers Pulmonary Silicosis

Valéria M. Borgesa, Haroldo Falcãoa, José H. Leite-Júniora, Luciana Alvima, Gerlinde P. Teixeirab, Momtchilo Russoc, Alberto F. Nóbregad, Marcela F. Lopesa, Patricia M. Roccoa, Wendy F. Davidsone, Rafael Lindena, Hideo Yagitaf, Walter A. Zina, and George A. DosReisa
a Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21944-970, Rio de Janeiro, Brazil
b Departamento de Imunobiologia, Universidade Federal Fluminense, Niterói 24001-970, Brazil
c Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo 05508-900, Brazil
d Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21944-970, Brazil
e Immunology Department, Holland Laboratory, American Red Cross, Rockville, Maryland 20850
f Juntendo University School of Medicine, Tokyo 113-8421, Japan

Correspondence to: George A. DosReis, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Ilha do Fundão, Rio de Janeiro 21944-970, Brazil. Tel:55-21-562 6522 Fax:55-21-280 8193 E-mail:gdosreis{at}biof.ufrj.br.

We investigated the role of Fas ligand in murine silicosis. Wild-type mice instilled with silica developed severe pulmonary inflammation, with local production of tumor necrosis factor (TNF)-{alpha}, and interstitial neutrophil and macrophage infiltration in the lungs. Strikingly, Fas ligand–deficient generalized lymphoproliferative disease mutant (gld) mice did not develop silicosis. The gld mice had markedly reduced neutrophil extravasation into bronchoalveolar space, and did not show increased TNF-{alpha} production, nor pulmonary inflammation. Bone marrow chimeras and local adoptive transfer demonstrated that wild-type, but not Fas ligand–deficient lung macrophages recruit neutrophils and initiate silicosis. Silica induced Fas ligand expression in lung macrophages in vitro and in vivo, and promoted Fas ligand–dependent macrophage apoptosis. Administration of neutralizing anti-Fas ligand antibody in vivo blocked induction of silicosis. Thus, Fas ligand plays a central role in induction of pulmonary silicosis.

Key Words: Fas ligand, silicosis, macrophages, neutrophils, inflammation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS